Bumper Offer - Urjas oil Just @ Rs. 1
Teczine CP Tablet (30), a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of Allergy, Allergic Rhinitis, Common Cold. Secondary and off-label uses of Teczine CP Tablet (30) have also been mentioned below.
The right dosage of Teczine CP Tablet (30) depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Teczine CP Tablet (30) side effects, there are can be others also. These have been listed below. These side effects of Teczine CP Tablet (30) are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Teczine CP Tablet (30)'s effect is Safe during pregnancy and Mild for lactating mothers. It is important to know if Teczine CP Tablet (30) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Teczine CP Tablet (30) related warnings section.
Other conditions have been mentioned below in the Teczine CP Tablet (30) contraindications section.
Drug interactions for Teczine CP Tablet (30) have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Teczine CP Tablet (30), it is important to know that it is not safe while driving, and is not habit-forming.
Teczine CP Tablet (30) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Teczine CP Tablet (30) is used -
Severe
Moderate
Mild
Is the use of Teczine CP Tablet (30) safe for pregnant women?
There are no side effects of Teczine in pregnant women.
Is the use of Teczine CP Tablet (30) safe during breastfeeding?
Teczine has been seen to have minimal side effects on breastfeeding women.
What is the effect of Teczine CP Tablet (30) on the Kidneys?
Very few cases of side effects of Teczine on kidney have been reported.
What is the effect of Teczine CP Tablet (30) on the Liver?
Using Teczine does not have any harmful effects on the liver.
What is the effect of Teczine CP Tablet (30) on the Heart?
Using Teczine does not have any harmful effects on the heart.
Teczine CP Tablet (30) should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Moderate
If you are suffering from any of the following diseases, you should not take Teczine CP Tablet (30) unless your doctor advises you to do so -
Is this Teczine CP Tablet (30) habit forming or addictive?
No, you will not get addicted to Teczine CP Tablet (30).
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Teczine CP Tablet (30) can make you feel drowsy.
Is it safe?
Teczine CP Tablet (30) is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Teczine CP Tablet (30) is unable to treat or cure mental disorders.
Interaction between Food and Teczine CP Tablet (30)
Taking Teczine CP Tablet (30) with food does not harm your health.
Interaction between Alcohol and Teczine CP Tablet (30)
Consumption of alcohol and Teczine CP Tablet (30) together may have severe effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xyzal® (levocetirizine dihydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,167
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xyzal® (levocetirizine dihydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,167
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xyzal® (levocetirizine dihydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,167
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xyzal® (levocetirizine dihydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,167
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xyzal® (levocetirizine dihydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,167
